CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
114 hedge funds and large institutions have $423M invested in Concert Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 37 increasing their positions, 23 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
+35
Holders Change %
+44.3%
% of All Funds
2.59%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
47
Increased
37
Reduced
23
Closed
11
Calls
$1.22M
Puts
$769K
Net Calls
+$452K
Net Calls Change
+$80K
Top Buyers
| 1 |
LCM
1
Laurion Capital Management
New York
|
$18.4M |
| 2 |
2
BlackRock
New York
|
$46.2M |
| 3 |
3
Millennium Management
New York
|
$18.8M |
| 4 |
BC
4
Boxer Capital
San Diego,
California
|
$10.3M |
| 5 |
5
Acadian Asset Management
Boston,
Massachusetts
|
$7.71M |
